DermaFocus Celebrates Successful Regional Launch Events for Celora™ Vita

Leading distributor DermaFocus has successfully concluded a series of regional launch events across the UK to introduce Celora™ Vita, its latest innovation in regenerative aesthetics, to healthcare professionals and aesthetic practitioners.

Bringing together members of the DermaFocus community from across the country, the events provided attendees with an in-depth exploration of the science, clinical applications, and treatment protocols behind Celora™ Vita. Practitioners also had the opportunity to hear first-hand experiences from DermaFocus Faculty Members, including Dr Racquel Amado and Dr Jordan Faulkner, alongside clinicians who have already begun incorporating the injectable treatment into their patient care plans.

Officially launched at this year’s Aesthetic Conference & Exhibition (ACE), Celora™ Vita represents a significant milestone for DermaFocus as the company’s first proprietary product. The innovative injectable has become the latest addition to the company’s established portfolio of advanced aesthetic solutions, further strengthening its position at the forefront of regenerative medicine.

The regional events formed part of DermaFocus’ ongoing commitment to practitioner education and professional development, ensuring clinics have access to the latest evidence-based innovations and treatment approaches within aesthetic medicine.

Speaking about the launch, Co-Founder and Executive Director of DermaFocus, Milad Bemana, said: “DermaFocus is committed to innovation and excellence in regenerative aesthetics, and the launch of Celora™ Vita marked a significant new chapter in our company’s history as we evolved to becoming a brand owner and category leader.

“Our Celora™ Vita regional launch events gave us a valuable opportunity to engage with our community at a regional level and allowed practitioners to connect with industry colleagues, deepen their understanding of the product, and explore how this innovative biorestorative treatment can support patient outcomes.

“We were delighted with the feedback from practitioners at each event, who are excited to introduce Celora™ Vita and the category of TRUE BIORESTORATION® to their patients and treatment menus.”

With strong engagement from practitioners and overwhelmingly positive feedback, the events have highlighted the growing interest in regenerative and biorestorative treatments. As DermaFocus continues to expand its educational initiatives and product portfolio, Celora™ Vita is set to play a key role in shaping the future of aesthetic medicine across the UK.